<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "12: marketing activities", fill: "#c2b280"},
{source: "12: marketing activities", target: "12: activities", fill: "#c2b280"},
{source: "12: activities", target: "12: United States ", fill: "#c2b280"},
{source: "12: United States ", target: "12: manufacturing", fill: "#c2b280"},
{source: "12: manufacturing", target: "12: facility", fill: "#c2b280"},
{source: "12: facility", target: "12: development", fill: "#c2b280"},
{source: "12: marketing activities", target: "20: generate sufficient cash flow from operations", fill: "#900"},
{source: "20: generate sufficient cash flow from operations", target: "20: operations", fill: "#900"},
{source: "20: operations", target: "20: additional financing", fill: "#900"},
{source: "20: additional financing", target: "20: delay curtail", fill: "#900"},
{source: "20: delay curtail", target: "20: manufacturing programs", fill: "#900"},
{source: "20: generate sufficient cash flow from operations", target: "47: Messenger ", fill: "#cc4e5c"},
{source: "47: Messenger ", target: "47: introduction", fill: "#cc4e5c"},
{source: "47: introduction", target: "47: began marketing employ", fill: "#cc4e5c"},
{source: "47: began marketing employ", target: "47: Messenger STS in January ", fill: "#cc4e5c"},
{source: "47: Messenger STS in January ", target: "47: MightyPlant in April ", fill: "#cc4e5c"},
{source: "47: Messenger ", target: "55: grower usage", fill: "#95b"},
{source: "55: grower usage", target: "55: Messenger ", fill: "#95b"},
{source: "55: Messenger ", target: "55: Messenger and Messenger STS ", fill: "#95b"},
{source: "55: Messenger and Messenger STS ", target: "55: distributors", fill: "#95b"},
{source: "55: distributors", target: "55: significant", fill: "#95b"},
{source: "55: significant", target: "55: inventories", fill: "#95b"},
{source: "55: inventories", target: "55: Messenger STS ", fill: "#95b"},
{source: "55: Messenger STS ", target: "55: distributors sold", fill: "#95b"},
{source: "55: distributors sold", target: "55: following amounts", fill: "#95b"},
{source: "55: grower usage", target: "66: marketing personnel", fill: "#fc9"},
{source: "66: marketing personnel", target: "66: specialists", fill: "#fc9"},
{source: "66: specialists", target: "66: inability", fill: "#fc9"},
{source: "66: inability", target: "66: effectively market", fill: "#fc9"},
{source: "66: effectively market", target: "66: current products", fill: "#fc9"},
{source: "66: current products", target: "66: could impair", fill: "#fc9"},
{source: "66: could impair", target: "66: gain market acceptance", fill: "#fc9"},
{source: "66: marketing personnel", target: "START_HERE", fill: "#fc9"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Pharmaceuticals Biotechnology and Life Sciences</td>
    </tr>
    <tr>
      <td>Biotechnology</td>
    </tr>
    <tr>
      <td>Food Distributors</td>
    </tr>
    <tr>
      <td>Trading Companies and Distributors</td>
    </tr>
    <tr>
      <td>Independent Power Producers and Energy Traders</td>
    </tr>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Automobile Manufacturers</td>
    </tr>
    <tr>
      <td>Motorcycle Manufacturers</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Ease</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Yield position</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Psychological state</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_Activities_Center">Special Activities Center</a></td>
      <td>The Special Activities Center (SAC) is a division of the Central Intelligence Agency responsible for covert operations and paramilitary operations. The unit was named Special Activities Division (SAD) prior to 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Manufacturing">Manufacturing</a></td>
      <td>Manufacturing is the creation or production of goods with the help of equipment, labor, machines, tools, and chemical or biological processing or formulation. It is the essence of secondary sector of the economy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arrested_Development">Arrested Development</a></td>
      <td>Arrested Development is an American television sitcom created by Mitchell Hurwitz, which originally aired on Fox for three seasons from  2003 to 2006, followed by a two-season revival on Netflix from 2013 to 2019. The show follows the Bluths, a formerly wealthy dysfunctional family.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Software_development">Software development</a></td>
      <td>Software development is the process of conceiving, specifying, designing, programming, documenting, testing, and bug fixing involved in creating and maintaining applications, frameworks, or other software components. Software development involves writing and maintaining the source code, but in a broader sense, it includes all processes from the conception of the desired software through to the final manifestation of the software, typically in a planned and structured process.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Research_and_development">Research and development</a></td>
      <td>Research and development (R&amp;D or R+D), known in Europe as research and technological development (RTD), is the set of innovative activities undertaken by corporations or governments in developing new services or products, and improving existing ones. Research and development constitutes the first stage of development of a potential new service or the production process.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Personal_development">Personal development</a></td>
      <td>Personal development or self improvement consists of activities that develop a person's capabilities and potential, build human capital, facilitate employability, and enhance quality of life and the realization of dreams and aspirations. Personal development may take place over the course of an individual's entire lifespan and is not limited to one stage of a person's life.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Prenatal_development">Prenatal development</a></td>
      <td>Prenatal development (from Latin  natalis 'relating to birth') includes the development of the embryo and of the foetus during a viviparous animal's gestation. Prenatal development starts with fertilization, in the germinal stage of embryonic development, and continues in fetal development until birth.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_management">Operations management</a></td>
      <td>Operations management is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. It involves the responsibility of ensuring that business operations are efficient in terms of using as few resources as needed and effective in meeting customer requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Met_Operations">Met Operations</a></td>
      <td>Met Operations, also known as Met Ops, is one of the four business groups which forms the Metropolitan Police Service. It was created during the 2018-19 restructuring of the service, amalgamating many of its functions from the Operations side of the Specialist Crime &amp; Operations Directorate formed in 2012, with the Specialist Crime side of that Directorate placed under the new Frontline Policing Directorate.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_(mathematics)">Operation (mathematics)</a></td>
      <td>In mathematics, an operation is a function which takes zero or more input values (called operands) to a well-defined output value. The number of operands (also known as arguments) is the arity of the operation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/MESSENGER">MESSENGER</a></td>
      <td>MESSENGER was a NASA robotic space probe that orbited the planet Mercury between 2011 and 2015, studying Mercury's chemical composition, geology, and magnetic field.  The name is a backronym for "Mercury Surface, Space Environment, Geochemistry, and Ranging", and a reference to the messenger god Mercury from Roman mythology.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Messenger_(software)">Messenger (software)</a></td>
      <td>Messenger is a proprietary instant messaging app and platform developed by Meta Platforms. Originally developed as Facebook Chat in 2008, the company revamped its messaging service in 2010, released standalone iOS and Android apps in 2011, and released standalone Facebook Portal hardware for Messenger calling in 2018.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Windows_Live_Messenger">Windows Live Messenger</a></td>
      <td>MSN Messenger (also known colloquially simply as "MSN"), later rebranded as Windows Live Messenger, is a discontinued cross-platform instant-messaging client developed by Microsoft. It connected to the Microsoft Messenger service and, in later versions, was compatible with Yahoo!</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Yahoo!_Messenger">Yahoo! Messenger</a></td>
      <td>Yahoo! Messenger (sometimes abbreviated Y!M) was an advertisement-supported instant messaging client and associated protocol provided by Yahoo!.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Messenger_RNA">Messenger RNA</a></td>
      <td>In molecular biology, messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein. \nmRNA is created during the process of transcription, where an enzyme (RNA polymerase) converts the gene into primary transcript mRNA (also known as pre-mRNA).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Prophets_and_messengers_in_Islam">Prophets and messengers in Islam</a></td>
      <td>Prophets in Islam (Arabic: الأنبياء في الإسلام, romanized: al-ʾAnbiyāʾ fī al-ʾIslām) are individuals in Islam who are believed to spread God's message on Earth and to serve as models of ideal human behaviour. Some prophets are categorized as messengers (Arabic: رسل, romanized: rusul, sing.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Windows_Messenger">Windows Messenger</a></td>
      <td>MSN Messenger (also known colloquially simply as "MSN"), later rebranded as Windows Live Messenger, is a discontinued cross-platform instant-messaging client developed by Microsoft. It connected to the Microsoft Messenger service and, in later versions, was compatible with Yahoo!</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Brewers'_Distributor">Brewers' Distributor</a></td>
      <td>Brewers' Distributor Ltd. (BDL) is a Canadian company that distributes beer throughout the four western provinces and three northern territories.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Quality_Distributors">Quality Distributors</a></td>
      <td>Quality Distributors FC are a professional association football (soccer) club in Guam. They play in the Guam Soccer League.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_film_distributors_by_country">List of film distributors by country</a></td>
      <td>This is a list of motion picture distributors, past and present, sorted alphabetically by country.\n\n\n== Albania ==\nConstantin Film\nUnited International Pictures\n\n\n== Argentina ==\nBuena Vista International\nWarner Bros.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Diamond_Comic_Distributors">Diamond Comic Distributors</a></td>
      <td>Diamond Comic Distributors, Inc. (often called Diamond Comics, DCD, or casually Diamond) is an American comic book distributor serving retailers in North America and worldwide.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sony_Pictures_Motion_Picture_Group">Sony Pictures Motion Picture Group</a></td>
      <td>Sony Pictures Entertainment Motion Picture Group (commonly known as Sony Pictures Motion Picture Group, formerly known as the Columbia TriStar Motion Picture Group until 2013, and abbreviated as SPMPG) is a division of Sony Pictures Entertainment to manage its motion picture operations. It was launched in 1998 by integrating the businesses of Columbia Pictures Industries, Inc.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/VMware">VMware</a></td>
      <td>VMware, Inc. is an American cloud computing and virtualization technology company with headquarters in Palo Alto, California.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Fisher_&amp;_Paykel">Fisher &amp; Paykel</a></td>
      <td>Fisher &amp; Paykel Appliances Holdings Ltd () is a major appliance manufacturer which is a subsidiary of Chinese multinational home appliance manufacturer Haier. It is a multinational corporation based in East Tamaki, New Zealand.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_Fitbit_products">List of Fitbit products</a></td>
      <td>This is a list of products released by Fitbit.\n\n\n== Current products ==\n\n\n=== Trackers ===\n\n\n==== Fitbit Ace range ====\nReleased in March 2018, the Fitbit Ace is the best version of the Alta for children aged 8 and above.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_Nokia_products">List of Nokia products</a></td>
      <td>The following is a list of products branded by Nokia.\n\n\n== Current products and services ==\n\n\n=== Products by Nokia Technologies ===\n\n\n==== Wi-Fi routers ====\nNokia WiFi Beacon 1\nNokia WiFi Beacon 3\n\n\n==== Digital audio ====\nNokia OZO Audio\n\n\n==== Smart TVs ====\nNokia markets smart TVs that run on Android TV.\n\nNokia Smart TV 55 inch\nNokia Smart TV 43 inch (to be launched on June 4, 2020)\n\n\n=== Products by Nokia Networks ===\nNokia Networks is a multinational data networking and telecommunications equipment company headquartered in Espoo, Finland and wholly owned subsidiary of Nokia Corporation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Smith's_Snackfood_Company">The Smith's Snackfood Company</a></td>
      <td>The Smith's Snackfood Company is a British-Australian snack food company owned by American multinational corporation PepsiCo. It is best known for its brand of potato crisps (potato chips).</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>EDEN BIOSCIENCE CORP      Item 1A    <font color="blue">Risk Factors</font></td>
    </tr>
    <tr>
      <td>Factors That May Affect Our Business, Future Operating Results and Financial     Condition       You <font color="blue">should carefully</font> consider the risks described below, <font color="blue">together with</font> all     of the other information included in this <font color="blue">Annual Report </font>on Form 10-K The     risks and <font color="blue"><font color="blue">uncertainties</font> described</font> below are not the <font color="blue">only ones facing</font> our     company</td>
    </tr>
    <tr>
      <td>If any of the <font color="blue">following risks actually</font> occurs, our business,     <font color="blue">financial condition</font> or operating results could be harmed</td>
    </tr>
    <tr>
      <td>19       _________________________________________________________________       We have a history of losses since inception, we expect to continue to incur     losses and we may not achieve or <font color="blue">sustain <font color="blue">profitability</font></font></td>
    </tr>
    <tr>
      <td>We have incurred operating losses in <font color="blue">each quarter since inception</font> and we     expect to continue to <font color="blue">incur further</font> operating losses for the foreseeable     future</td>
    </tr>
    <tr>
      <td>From our inception in July 1994 to <font color="blue">December </font>31, 2005, we have     <font color="blue">accumulated</font> a deficit of dlra116dtta8 million</td>
    </tr>
    <tr>
      <td>For the years ended <font color="blue">December </font>31,     2005, 2004, 2003, 2002 and 2001, we had net losses of dlra10dtta9 million, dlra8dtta9     million, dlra11dtta2 million, dlra23dtta5 million and dlra23dtta7 million, respectively</td>
    </tr>
    <tr>
      <td>For example, there were no sales in     the <font color="blue">fourth quarter</font> of 2001 and <font color="blue">annual net sales</font> decreased from dlra3dtta5 million     in 2001 to dlra1dtta9 million in 2002, dlra1dtta8 million in 2003 and dlra1dtta0 million in     2004</td>
    </tr>
    <tr>
      <td>Our <font color="blue">annual net sales</font> were dlra3dtta8 million in 2005</td>
    </tr>
    <tr>
      <td>We expect our future     revenues  to  come  primarily  from the sale of <font color="blue">Messenger </font>STS, employ,     MightyPlant, ProAct™, N-Hibit™ and other products and these sales are highly     uncertain</td>
    </tr>
    <tr>
      <td>We expect to continue to devote substantial resources to funding sales and     <font color="blue">marketing <font color="blue">activities</font></font> in the <font color="blue">United States </font>and <font color="blue">foreign countries</font>, maintaining     and  operating our <font color="blue">manufacturing</font> <font color="blue">facility</font> and funding our research and     <font color="blue">development</font> <font color="blue">activities</font></td>
    </tr>
    <tr>
      <td>As a result, we will need to generate <font color="blue">significant</font>     revenues  to achieve and maintain <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>We may never generate     profits, and if we do become profitable, we may be unable to sustain or     increase <font color="blue">profitability</font> on a quarterly or <font color="blue">annual basis</font></td>
    </tr>
    <tr>
      <td>We currently anticipate that our operating expenses will <font color="blue">significant</font>ly     exceed  net  product  sales  and  that  net losses and working capital     <font color="blue"><font color="blue">requirement</font>s will consume</font> a material amount of our <font color="blue">cash resources</font></td>
    </tr>
    <tr>
      <td>If net     <font color="blue">product sales</font> do not <font color="blue">significant</font>ly increase in the near term, we will have     to <font color="blue">further reduce</font> our operating expenses</td>
    </tr>
    <tr>
      <td>We believe that the balance of our     cash and <font color="blue">cash equivalents at</font> <font color="blue">December </font>31, 2005 will be sufficient to meet     our anticipated cash needs for net losses, working capital and capital     <font color="blue">expenditures</font> for more than the next 12 months, although there can be no     assurance in that regard</td>
    </tr>
    <tr>
      <td>We may have to reduce or <font color="blue">cease <font color="blue">operations</font></font> if we are unable to meet our     <font color="blue">funding <font color="blue">requirement</font>s</font></td>
    </tr>
    <tr>
      <td>We will require substantial <font color="blue"><font color="blue">additional</font> funding</font> to continue our sales and     marketing and research and <font color="blue">development</font> <font color="blue">activities</font> in the <font color="blue">United States </font>and     <font color="blue">foreign countries</font> and to maintain and operate our <font color="blue">manufacturing</font> <font color="blue">facilities</font></td>
    </tr>
    <tr>
      <td>If we are unable to <font color="blue">generate sufficient cash flow from <font color="blue">operations</font></font>, or obtain     funds  through  <font color="blue"><font color="blue">additional</font> financing</font>, we may have to delay, curtail or     eliminate  some or all of our research and <font color="blue">development</font>, field-testing,     marketing or <font color="blue">manufacturing</font> programs or cease all <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>For example, we     reduced  our  workforce  by  34prca  in  May 2003 and by 23prca in May 2002,     <font color="blue">significant</font>ly curtailing certain research and <font color="blue">development</font> <font color="blue">activities</font> and our     <font color="blue">European and Mexican </font><font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">future capital <font color="blue">requirement</font>s will depend</font>     on the success of our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>If our <font color="blue">capital <font color="blue">requirement</font>s vary from</font> our current plans, we may require     <font color="blue"><font color="blue">additional</font> financing</font> sooner than we anticipate</td>
    </tr>
    <tr>
      <td><font color="blue">Financing </font>may be unavailable     to us when needed or on acceptable terms</td>
    </tr>
    <tr>
      <td>Our <font color="blue"><font color="blue">common stock</font> listing</font> was <font color="blue">transferred from</font> <font color="blue"><font color="blue">The Nasdaq National Market</font> </font>to     <font color="blue">The Nasdaq Capital Market </font>(<font color="blue">formerly known as</font> The Nasdaq SmallCap Market); we     currently are not in <font color="blue">compliance with</font> <font color="blue">The Nasdaq Capital Market </font><font color="blue">minimum bid</font>     <font color="blue">requirement</font> and failure to regain and maintain <font color="blue">compliance with</font> this and     other <font color="blue"><font color="blue">continued listing</font> standards could</font> result in delisting and <font color="blue">adversely</font>     affect our <font color="blue">market price</font> and liquidity</td>
    </tr>
    <tr>
      <td>Our <font color="blue"><font color="blue">common stock</font> listing</font> was <font color="blue">transferred from</font> <font color="blue"><font color="blue">The Nasdaq National Market</font> </font>to     <font color="blue">The Nasdaq Capital Market </font>on October 10, 2005</td>
    </tr>
    <tr>
      <td>We elected to seek a transfer     to <font color="blue">The Nasdaq Capital Market </font>because we had <font color="blue">been unable</font> to <font color="blue">regain compliance</font>     with Nasdaq’s minimum dlra1dtta00 bid price <font color="blue">requirement</font> for <font color="blue">continued listing</font></td>
    </tr>
    <tr>
      <td>By     <font color="blue">transferring</font>  to  The  Nasdaq Capital Market, we have <font color="blue">been afforded</font> an     <font color="blue">additional</font> 180-calendar day grace period, or until March 31, 2006, in which     to  satisfy  Nasdaq’s  dlra1dtta00  <font color="blue">minimum bid</font> price <font color="blue">requirement</font></td>
    </tr>
    <tr>
      <td>To regain     compliance, the closing bid price of our <font color="blue">common stock</font> has to remain at dlra1dtta00     per share or more for a minimum of <font color="blue">ten consecutive trading days</font></td>
    </tr>
    <tr>
      <td>If we do     not regain <font color="blue">compliance with</font> the <font color="blue">minimum bid</font> price rule by March 31, 2006,     which as of the date of this report we have <font color="blue">been unable</font> to do, Nasdaq will     <font color="blue">provide us written notification</font> that our <font color="blue">common stock</font> will be delisted</td>
    </tr>
    <tr>
      <td>In     such case, we have the right to appeal Nasdaq’s <font color="blue">delisting determination</font> to a     <font color="blue">Listing Qualifications Panel</font></td>
    </tr>
    <tr>
      <td>In order to regain <font color="blue">compliance with</font> the minimum                                         20       _________________________________________________________________       bid price <font color="blue">requirement</font>, our <font color="blue">Board of Directors </font><font color="blue">may approve</font> a reverse stock     split of our <font color="blue">common stock</font>, although there can be no assurance that a reverse     <font color="blue">stock split would allow us</font> to meet the <font color="blue">minimum bid</font> price <font color="blue">requirement</font> for the     required period of time</td>
    </tr>
    <tr>
      <td>Trading on <font color="blue">The Nasdaq Capital Market </font>may have a <font color="blue">negative <font color="blue">impact on</font></font> the value     of our <font color="blue">common stock</font>, because <font color="blue">securities trading on</font> <font color="blue">The Nasdaq Capital Market </font>    typically are <font color="blue">less liquid than</font> those traded on <font color="blue">The Nasdaq National Market</font></td>
    </tr>
    <tr>
      <td>Furthermore, we will not be eligible to relist our <font color="blue">common stock</font> on The     Nasdaq National Market unless and until our <font color="blue">common stock</font> maintains a minimum     bid  price  of  dlra5dtta00 per share for 90 consecutive trading days and we     otherwise  <font color="blue">comply with</font> the initial listing <font color="blue">requirement</font>s for The Nasdaq     National Market</td>
    </tr>
    <tr>
      <td>If our <font color="blue">common stock</font> were to be <font color="blue">delisted from</font> The Nasdaq Capital Market, we     <font color="blue">may seek <font color="blue">quotation on</font></font> a <font color="blue">regional stock exchange</font>, if available</td>
    </tr>
    <tr>
      <td>Such listing     <font color="blue">could reduce</font> the <font color="blue">market liquidity</font> for our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>If our <font color="blue">common stock</font>     is not eligible for <font color="blue">quotation on</font> another market or exchange, trading of our     common  stock  could be conducted in the over-the-counter market on an     <font color="blue">electronic bulletin board established</font> for <font color="blue">unlisted securities such as</font> the     <font color="blue">Pink Sheets or the OTC Bulletin Board</font></td>
    </tr>
    <tr>
      <td>As a result, an investor would find     it more <font color="blue">difficult</font> to dispose of, or obtain accurate quotations for the price     of, our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>If our <font color="blue">common stock</font> is <font color="blue">delisted from</font> The Nasdaq Capital Market, and if we     fail to obtain <font color="blue">quotation on</font> another market or exchange, and if the trading     price remains below dlra5dtta00 per share, then trading in our <font color="blue">common stock</font> might     also become subject to the <font color="blue">requirement</font>s of <font color="blue">certain rules promulgated under</font>     the Securities Exchange Act of 1934, which require <font color="blue">additional</font> <font color="blue">disclosure</font> by     broker-dealers in <font color="blue">connection</font> with any trade involving a stock defined as a     “penny stock” (<font color="blue">generally</font>, any equity security not listed on a national     securities exchange or quoted on Nasdaq that has a <font color="blue">market price</font> of less than     dlra5dtta00 per share, subject to <font color="blue">certain exceptions</font>)</td>
    </tr>
    <tr>
      <td>Many <font color="blue">brokerage firms</font> are     reluctant to recommend low-priced stocks to their clients</td>
    </tr>
    <tr>
      <td>Moreover, various     <font color="blue">regulations</font> and <font color="blue">policies restrict</font> the ability of <font color="blue">shareholders</font> to borrow     against or “margin” low-priced stocks, and declines in the stock price below     <font color="blue">certain levels may trigger unexpected margin calls</font></td>
    </tr>
    <tr>
      <td>Additionally, because     brokers’ commissions on low-priced stocks <font color="blue">generally</font> represent a higher     percentage of the stock price than commissions on higher priced stocks, the     <font color="blue">current price</font> of the <font color="blue">common stock</font> can result in an individual shareholder     <font color="blue">paying transaction costs</font> that represent a <font color="blue">higher percentage</font> of total share     <font color="blue">value than would</font> be the case if our share price were higher</td>
    </tr>
    <tr>
      <td>This factor may     <font color="blue">also limit</font> the <font color="blue">willingness</font> of <font color="blue">institutions</font> to purchase our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>Finally,  the  <font color="blue">additional</font> burdens imposed upon broker-dealers by these     <font color="blue">requirement</font>s could discourage broker-dealers from <font color="blue">facilitating</font> trades in our     <font color="blue">common stock</font>, which could severely limit the <font color="blue">market liquidity</font> of the stock     and the ability of investors to trade our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">currently depend on products</font> that are <font color="blue">based on</font> the <font color="blue">same <font color="blue">new <font color="blue">technology</font></font></font>,     and our <font color="blue">development</font> and <font color="blue">commercialization</font> of those <font color="blue">products may</font> not be     successful</td>
    </tr>
    <tr>
      <td>For  the  <font color="blue">immediately</font>  foreseeable  future we will be <font color="blue">dependent</font> on the     successful  <font color="blue">development</font>  and  <font color="blue">commercialization</font> of six products in our     Harp-N-Tek <font color="blue">product portfolio</font> (Messenger, <font color="blue">Messenger </font>STS, ProAct, N-Hibit,     employ and MightyPlant) which are <font color="blue">based on</font> the <font color="blue">same <font color="blue">new <font color="blue">technology</font></font></font></td>
    </tr>
    <tr>
      <td>We have     had only limited sales of <font color="blue">Messenger </font>since its <font color="blue">introduction</font> in August 2000     and we <font color="blue">began marketing employ</font> in November 2003, <font color="blue"><font color="blue">Messenger </font>STS </font>in January     2004, <font color="blue">MightyPlant </font>in April 2004 and N-Hibit and ProAct in early 2005</td>
    </tr>
    <tr>
      <td><font color="blue">These     </font>six <font color="blue">products may</font> not be <font color="blue">commercially successful</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">products may</font> not prove     <font color="blue">effective</font> or <font color="blue">economically viable</font> for all crops or markets</td>
    </tr>
    <tr>
      <td>In addition,     because our products have not been put to <font color="blue">widespread <font color="blue">commercial use</font> over</font>     <font color="blue">significant</font>  periods  of  time, no assurance can be given that adverse     <font color="blue">consequences</font>  might  not  result from their use, such as soil or other     <font color="blue"><font color="blue">environment</font>al degradation</font>, the <font color="blue">development</font> of <font color="blue">negative effects on animals</font> or     plants or <font color="blue">reduced benefits</font> in terms of crop yield or protection</td>
    </tr>
    <tr>
      <td>Our products have not gained, and may not gain, commercial     <font color="blue">acceptance</font> or success</td>
    </tr>
    <tr>
      <td>If we are unable to <font color="blue">successfully</font> achieve <font color="blue">broad market</font>     <font color="blue">acceptance</font> of our products, we may not be able to <font color="blue">generate enough product</font>     revenues in the future to achieve <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>A variety of <font color="blue">factors will</font>     determine  the success of our market <font color="blue">development</font> and <font color="blue">commercialization</font>     efforts  and the rate and extent of market <font color="blue">acceptance</font> of our products,     including our ability to                                         21       _________________________________________________________________       implement and maintain an <font color="blue">appropriate pricing policy</font> and <font color="blue">general economic</font>     <font color="blue">conditions</font> in <font color="blue">agricultural markets</font>, including commodity prices, climatic     <font color="blue">conditions</font> and the extent that growers, <font color="blue">regulatory</font> authorities and the     <font color="blue">public accept new agricultural practices</font> and products developed through     <font color="blue">bio<font color="blue">technology</font></font></td>
    </tr>
    <tr>
      <td>We have experienced limited <font color="blue">grower usage</font> of <font color="blue">Messenger </font>and <font color="blue">Messenger </font>STS, and     in<font color="blue">dependent</font> <font color="blue"><font color="blue">distributor</font>s</font> hold <font color="blue">significant</font> <font color="blue">inventories</font> of <font color="blue"><font color="blue">Messenger </font>STS </font>      Based  on  information  received  from  <font color="blue"><font color="blue">distributor</font>s</font>, we estimate that     <font color="blue"><font color="blue">distributor</font>s</font> sold the <font color="blue">following amounts</font> of <font color="blue">Messenger </font>and/or <font color="blue"><font color="blue">Messenger </font>STS </font>to     growers: 66cmam000 ounces in 2000, 596cmam000 ounces in 2001, 684cmam000 ounces in     2002, 734cmam000 ounces in 2003, 800cmam000 ounces in 2004 and 860cmam000 in 2005</td>
    </tr>
    <tr>
      <td>We     estimate that <font color="blue">Messenger </font>and <font color="blue"><font color="blue">Messenger </font>STS </font>inventory held by <font color="blue"><font color="blue">distributor</font>s</font> at     <font color="blue">December </font>31, 2005 was <font color="blue">approximately</font> 309cmam000 ounces</td>
    </tr>
    <tr>
      <td>We sent <font color="blue"><font color="blue">distributor</font>s</font>     <font color="blue">approximately</font> 470cmam000 ounces of <font color="blue">additional</font> <font color="blue"><font color="blue">Messenger </font>STS </font>for free in 2004 as     part of an effort to lower the <font color="blue">average cost</font> of their year-end <font color="blue">Messenger </font>    <font color="blue">inventories</font> by <font color="blue">approximately</font> 50prca</td>
    </tr>
    <tr>
      <td>This <font color="blue">free product</font> <font color="blue">significant</font>ly increased     <font color="blue">channel inventory</font> and <font color="blue">negatively affected</font> our sales to <font color="blue"><font color="blue">distributor</font>s</font></td>
    </tr>
    <tr>
      <td>We do     not expect <font color="blue"><font color="blue">distributor</font>s</font> that hold <font color="blue">significant</font> <font color="blue">inventories</font> of <font color="blue">Messenger </font>or     <font color="blue">Messenger </font> STS to place <font color="blue">additional</font> orders for our products until their     current <font color="blue">inventories</font> are reduced, which will <font color="blue">adversely</font> affect our sales and     results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Inability </font>to develop adequate sales and marketing <font color="blue">cap<font color="blue">abilities</font></font> could prevent     us from <font color="blue">successfully</font> <font color="blue">commercializing</font> our <font color="blue">current products</font> and other products     we may develop</td>
    </tr>
    <tr>
      <td>We currently have limited sales and marketing experience and <font color="blue">cap<font color="blue">abilities</font></font></td>
    </tr>
    <tr>
      <td>Our  <font color="blue">internal sales</font> and <font color="blue">marketing staff consist primarily</font> of sales and     <font color="blue">marketing <font color="blue">specialists</font></font> who are trained to <font color="blue">educate growers</font> and in<font color="blue">dependent</font>     <font color="blue"><font color="blue">distributor</font>s</font> on the uses and benefits of our products</td>
    </tr>
    <tr>
      <td>We will need to     further develop our sales and marketing <font color="blue">cap<font color="blue">abilities</font></font> in order to enhance our     <font color="blue">commercialization</font> efforts, which will involve substantial costs</td>
    </tr>
    <tr>
      <td><font color="blue">These     </font><font color="blue">specialists</font>  require a <font color="blue">high level</font> of <font color="blue">technical expertise</font> and knowledge     regarding our products’ <font color="blue">cap<font color="blue">abilities</font></font> and other <font color="blue">plant protection</font> and yield     <font color="blue">enhancement</font>  products  and  <font color="blue">techniques</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot assure</font> you that our     <font color="blue">specialists</font>  and  other  members  of our sales and <font color="blue">marketing team will</font>     <font color="blue">successfully</font> compete against the sales and marketing <font color="blue">operations</font> of our     current and <font color="blue">future <font color="blue">competitors</font></font> that may have more <font color="blue">established <font color="blue">relationships</font></font>     with <font color="blue"><font color="blue">distributor</font>s</font>, retailers and growers</td>
    </tr>
    <tr>
      <td>Failure to recruit, train and     retain  important sales and <font color="blue">marketing personnel</font>, such as our sales and     <font color="blue">marketing <font color="blue">specialists</font></font>, or the <font color="blue">inability</font> of new sales and <font color="blue">marketing personnel</font>     to <font color="blue">effective</font>ly market and sell our <font color="blue">current products</font> and other products we     may develop, <font color="blue">could impair</font> our ability to gain market <font color="blue">acceptance</font> of our     products and cause our sales to suffer</td>
    </tr>
    <tr>
      <td>We may be unable to establish or maintain <font color="blue">successful <font color="blue">relationships</font> with</font>     in<font color="blue">dependent</font> <font color="blue"><font color="blue">distributor</font>s</font> and retailers, which could <font color="blue">adversely</font> affect our     sales</td>
    </tr>
    <tr>
      <td>We  intend  to  rely  on  in<font color="blue">dependent</font>  <font color="blue"><font color="blue">distributor</font>s</font>  and  retailers of     agri-chemicals to distribute and <font color="blue">assist with</font> the marketing and sale of our     <font color="blue">current products</font> and any other products we may develop</td>
    </tr>
    <tr>
      <td>We have engaged     several in<font color="blue">dependent</font> <font color="blue"><font color="blue">distributor</font>s</font> and retailers for the <font color="blue">distribution</font> and sale     of our products</td>
    </tr>
    <tr>
      <td>Our <font color="blue">future revenue growth will depend</font> in large part on our     success  in  <font color="blue">establishing</font> and maintaining these sales and <font color="blue">distribution</font>     channels</td>
    </tr>
    <tr>
      <td>We are continuing to develop our <font color="blue">distribution</font> network and we may     be  unable to establish or maintain these <font color="blue">relationships</font> in a timely or     cost-<font color="blue">effective</font> manner</td>
    </tr>
    <tr>
      <td>Moreover, we <font color="blue">cannot assure</font> you that the <font color="blue"><font color="blue">distributor</font>s</font>     and <font color="blue">retailers on which</font> we <font color="blue">rely will focus adequate resources on selling</font>     these products or will be successful in <font color="blue">selling them</font></td>
    </tr>
    <tr>
      <td>Many of our potential     <font color="blue"><font color="blue">distributor</font>s</font> and retailers are in the business of <font color="blue">distributing</font> and sometimes     <font color="blue">manufacturing</font>  other,  possibly  competing, <font color="blue">plant protection</font> and yield     <font color="blue">enhancement</font> products and may perceive our <font color="blue">products as</font> a threat to various     product  <font color="blue">lines currently</font> being <font color="blue"><font color="blue">manufacture</font>d</font> or <font color="blue">distributed by them</font></td>
    </tr>
    <tr>
      <td>In     addition, the <font color="blue"><font color="blue">distributor</font>s</font> and <font color="blue">retailers may earn higher margins by selling</font>     <font color="blue">competing products</font> or <font color="blue">combinations</font> of <font color="blue">competing products</font></td>
    </tr>
    <tr>
      <td>If we are unable     to  establish  or  maintain  <font color="blue">successful <font color="blue">relationships</font> with</font> in<font color="blue">dependent</font>     <font color="blue"><font color="blue">distributor</font>s</font>  and  retailers,  we will need to further develop our own     <font color="blue">distribution</font> and sales and marketing <font color="blue">cap<font color="blue">abilities</font></font>, <font color="blue">which would</font> be expensive     and time-consuming and the success of <font color="blue">which would</font> be uncertain</td>
    </tr>
    <tr>
      <td>Five <font color="blue"><font color="blue">distributor</font>s</font> accounted for an aggregate of 59prca of net <font color="blue">product sales</font>     revenue in 2005, three <font color="blue"><font color="blue">distributor</font>s</font> accounted for an aggregate of 46prca of our     <font color="blue">net sales revenue</font> in 2004 and three <font color="blue"><font color="blue">distributor</font>s</font> accounted for an                                         22       _________________________________________________________________       aggregate of 40prca of our <font color="blue">net sales revenue</font> in 2003</td>
    </tr>
    <tr>
      <td>If any <font color="blue">distributor</font> that     purchases  a  <font color="blue">significant</font>  amount  of our products were to <font color="blue">discontinue</font>     purchasing our products at any time, our <font color="blue">sales would</font> be <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>In addition, the failure of any of these <font color="blue"><font color="blue">distributor</font>s</font>, or of any other     <font color="blue">distributor</font> to which we extend a <font color="blue">significant</font> amount of credit, to pay its     account, now or in the future, may harm our operating results</td>
    </tr>
    <tr>
      <td>If our ongoing or <font color="blue"><font color="blue">future field</font> trials</font> are <font color="blue">unsuccessful</font>, we may be unable to     achieve market <font color="blue">acceptance</font> or obtain <font color="blue"><font color="blue">regulatory</font> approval</font> of our current     products or any other products we may develop</td>
    </tr>
    <tr>
      <td>The successful completion of <font color="blue">multiple field trials</font> in domestic and foreign     <font color="blue">locations on</font> a wide variety of crops is critical to the success of our     product <font color="blue">development</font> and <font color="blue">marketing efforts</font></td>
    </tr>
    <tr>
      <td>If our ongoing or <font color="blue">future field</font>     trials are <font color="blue">unsuccessful</font> or produce <font color="blue">inconsistent</font> results or adverse side     effects, or if we are unable to collect reliable data, <font color="blue"><font color="blue">regulatory</font> approval</font>     of  our <font color="blue">current products</font> or any other products we may develop could be     delayed or withheld or we may be unable to achieve market <font color="blue">acceptance</font> of     these products</td>
    </tr>
    <tr>
      <td>Although we have <font color="blue">conducted successful field trials on</font> a     <font color="blue">broad range</font> of crops, we cannot be certain that <font color="blue">additional</font> field trials     <font color="blue">conducted on</font> a greater number of acres, or on crops for which we have not     yet conducted field trials, will be successful</td>
    </tr>
    <tr>
      <td>Moreover, the results of our     ongoing and <font color="blue"><font color="blue">future field</font> trials</font> are subject to a number of <font color="blue">conditions</font> beyond     our control, including weather-related events such as droughts and floods,     <font color="blue">severe heat</font> and frost, hail, tornadoes and hurricanes</td>
    </tr>
    <tr>
      <td>Generally, we pay     <font color="blue">third parties</font>, such as consultants and <font color="blue">universities</font>, to conduct our field     trials for us</td>
    </tr>
    <tr>
      <td><font color="blue">Incompatible </font><font color="blue">crop treatment practices</font> or <font color="blue">misapplication</font> of     the <font color="blue">product by <font color="blue">third parties</font> could interfere with</font> the success of our field     trials</td>
    </tr>
    <tr>
      <td>We are largely in the <font color="blue">development</font> stage and are subject to the risks of a     <font color="blue">new enterprise</font> and the <font color="blue">commercialization</font> of a <font color="blue">new <font color="blue">technology</font></font></td>
    </tr>
    <tr>
      <td>We began our <font color="blue">operations</font> in 1994 and began the marketing and sale of our     first  product,  Messenger, in the <font color="blue">third quarter</font> of 2000</td>
    </tr>
    <tr>
      <td>Our stage of     <font color="blue">development</font>, our <font color="blue">novel <font color="blue">technology</font></font> and the uncertain nature of the market in     which we compete make it <font color="blue">difficult</font> to assess our prospects or predict our     future  operating  results</td>
    </tr>
    <tr>
      <td>We are subject to risks and <font color="blue">uncertainties</font>     <font color="blue">frequently <font color="blue">encountered</font></font> in the <font color="blue">establishment</font> of a new business enterprise,     <font color="blue">particularly</font> in the rapidly changing market for <font color="blue">plant protection</font> and yield     <font color="blue">enhancement</font> products</td>
    </tr>
    <tr>
      <td>These risks include our <font color="blue">inability</font> to develop a company     capable  of supporting commercial <font color="blue">activities</font>, including <font color="blue">manufacturing</font>,     quality  control  and  assurance,  <font color="blue"><font color="blue">regulatory</font> approval</font> and compliance,     marketing,  sales, <font color="blue">distribution</font> and <font color="blue">customer service</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">inability</font> to     <font color="blue"><font color="blue">adequately</font> address</font> these <font color="blue">risks could</font> cause us to be unprofitable or to cease     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue"><font color="blue">International </font> </font>expansion  will  subject  us  to  <font color="blue">risks associated with</font>     international <font color="blue">operations</font>, which could <font color="blue">adversely</font> affect both our domestic and     international <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">success depends</font> in part on our ability to <font color="blue">expand <font color="blue">internationally</font> as</font> we     obtain <font color="blue"><font color="blue">regulatory</font> approval</font>s to market and sell our <font color="blue">current products</font>, and any     other products we may develop, in other countries</td>
    </tr>
    <tr>
      <td>We received <font color="blue">registration</font>     to sell <font color="blue">Messenger </font>in Spain in March of 2004</td>
    </tr>
    <tr>
      <td>We have <font color="blue">been conducting field</font>     trials in <font color="blue">several international locations</font> and we have personnel in Europe to     develop <font color="blue">operations</font> in that region</td>
    </tr>
    <tr>
      <td><font color="blue">International </font>expansion of our <font color="blue">operations</font>     <font color="blue">could impose</font> substantial <font color="blue">burdens on</font> our resources, divert <font color="blue">management</font>’s     attention  from  domestic <font color="blue">operations</font> or otherwise <font color="blue">adversely</font> affect our     business</td>
    </tr>
    <tr>
      <td>Furthermore, international <font color="blue">operations</font> are subject to several     inherent  risks, such as <font color="blue">different</font> <font color="blue">regulatory</font> <font color="blue">requirement</font>s and reduced     protection of <font color="blue"><font color="blue">intellectual</font> property</font> rights, which could <font color="blue">adversely</font> affect our     ability to compete in <font color="blue">international markets</font> and could have a negative effect     on our operating results</td>
    </tr>
    <tr>
      <td>The <font color="blue">high level</font> of <font color="blue">competition</font> in our market may result in <font color="blue">price reductions</font>,     reduced  margins  or  the  <font color="blue">inability</font> of our products to achieve market     <font color="blue">acceptance</font></td>
    </tr>
    <tr>
      <td>The market for <font color="blue">plant protection</font> and yield <font color="blue">enhancement</font> products is intensely     competitive, rapidly changing and <font color="blue">undergoing consolidation</font></td>
    </tr>
    <tr>
      <td>We may be unable     to compete <font color="blue">successfully</font> against our current or <font color="blue">future <font color="blue">competitors</font></font>, which may     result in <font color="blue">price reductions</font>, reduced margins or the <font color="blue">inability</font> to achieve     market <font color="blue">acceptance</font> of our <font color="blue">current products</font> or any other products we may     develop</td>
    </tr>
    <tr>
      <td>For example, from <font color="blue">September </font>to                                         23       _________________________________________________________________       <font color="blue">December </font>2003 we offered growers a “buy one, get one free” promotion and in     January 2004 we introduced <font color="blue"><font color="blue">Messenger </font>STS </font>at a price that is <font color="blue">approximately</font>     50prca of the 2003 price of Messenger</td>
    </tr>
    <tr>
      <td>Many  companies  are  engaged in developing <font color="blue">plant protection</font> and yield     <font color="blue">enhancement</font>  products</td>
    </tr>
    <tr>
      <td>Our  <font color="blue">competitors</font>  include  <font color="blue">major international</font>     agri-chemical companies, specialized <font color="blue">bio<font color="blue">technology</font></font> companies and research     and academic <font color="blue">institutions</font></td>
    </tr>
    <tr>
      <td>Many of these <font color="blue">organizations</font> have <font color="blue">significant</font>ly     more  capital,  research  and  <font color="blue">development</font>, <font color="blue">regulatory</font>, <font color="blue">manufacturing</font>,     <font color="blue">distribution</font>, sales, marketing, human and other <font color="blue">resources than</font> we do</td>
    </tr>
    <tr>
      <td>As a     result, they may be able to devote <font color="blue">greater resources</font> to the <font color="blue">development</font>,     <font color="blue">manufacture</font>, promotion or sale of their products, receive <font color="blue">greater resources</font>     and support from in<font color="blue">dependent</font> <font color="blue"><font color="blue">distributor</font>s</font>, initiate or withstand substantial     price <font color="blue">competition</font> or take advantage of <font color="blue">acquisition</font> or other <font color="blue">opportunities</font>     more readily</td>
    </tr>
    <tr>
      <td>Furthermore, these large agri-chemical companies have a more     <font color="blue">diversified product offering than</font> we do, <font color="blue">which may give them</font> an advantage in     <font color="blue">meeting customer</font> needs <font color="blue">by enabling them</font> to <font color="blue">offer integrated solutions</font> to     <font color="blue">plant protection</font> and yield <font color="blue">enhancement</font></td>
    </tr>
    <tr>
      <td>Age and actual storage <font color="blue">conditions</font> of our <font color="blue">products may</font> cause them to degrade,     which  could <font color="blue">adversely</font> affect market <font color="blue">acceptance</font> of our products or our     results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our products are currently being stored in large <font color="blue">quantities under various</font>     <font color="blue">conditions</font> by us and by <font color="blue"><font color="blue">distributor</font>s</font></td>
    </tr>
    <tr>
      <td>Most of this material was <font color="blue"><font color="blue">manufacture</font>d</font>     in 2002, 2004 and 2005</td>
    </tr>
    <tr>
      <td>The results of re-testing of <font color="blue">Messenger </font><font color="blue"><font color="blue">manufacture</font>d</font>     in 2000 indicate that it is <font color="blue">still stable with</font> similar <font color="blue">biological activity</font>     and <font color="blue">performance as</font> of the <font color="blue">original <font color="blue">manufacture</font> date</font></td>
    </tr>
    <tr>
      <td>No assurance can be     given,  however,  that  actual  storage  <font color="blue">conditions</font> will not cause our     products’ quality to <font color="blue">degrade over</font> a shorter time period</td>
    </tr>
    <tr>
      <td>The inventory of <font color="blue"><font color="blue">Messenger </font>STS </font>held by us and by <font color="blue"><font color="blue">distributor</font>s</font> is aging and     may not meet our <font color="blue">quality standards</font>, which could <font color="blue">adversely</font> affect market     <font color="blue">acceptance</font> of our products and our results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Our inventory at <font color="blue">December </font>31, 2005 includes <font color="blue">approximately</font> 2dtta1 million ounces     of <font color="blue"><font color="blue">Messenger </font>STS </font>that was <font color="blue"><font color="blue">manufacture</font>d</font> in 2002 and 2004</td>
    </tr>
    <tr>
      <td>In addition, we     estimate that <font color="blue"><font color="blue">distributor</font>s</font> own <font color="blue">approximately</font> 239cmam000 ounces of <font color="blue">Messenger </font>and     <font color="blue"><font color="blue">Messenger </font>STS </font>that was <font color="blue"><font color="blue">manufacture</font>d</font> between 2002 and 2004</td>
    </tr>
    <tr>
      <td>We conducted     limited re-testing of <font color="blue">Messenger </font>samples produced in 2000 and 2001</td>
    </tr>
    <tr>
      <td>In 2003,     we  <font color="blue">voluntarily</font>  recalled  and replaced <font color="blue">approximately</font> 10cmam000 ounces of     <font color="blue">Messenger </font>owned by <font color="blue"><font color="blue">distributor</font>s</font> that our limited re-testing indicated had     degraded below our <font color="blue">quality control standards</font></td>
    </tr>
    <tr>
      <td>Although results of our limited re-testing in 2004 indicated that almost all     of inventory <font color="blue"><font color="blue">manufacture</font>d</font> in 2001 and 2002 continues to meet our quality     standards, no assurance can be given that this material <font color="blue">will continue</font> to     meet our <font color="blue">quality standards</font>, nor can we predict if or when this material     might fail to meet our <font color="blue">quality standards</font></td>
    </tr>
    <tr>
      <td>If re-testing indicates that     <font color="blue">additional</font> material has degraded below our <font color="blue">quality standards</font>, we may have to     record <font color="blue">additional</font> inventory write-downs and, although we are not required     to, may choose to replace any <font color="blue">such product</font> owned by <font color="blue"><font color="blue">distributor</font>s</font> or growers,     which could <font color="blue">adversely</font> affect the market <font color="blue">acceptance</font> of our products or our     results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Inability </font>to obtain <font color="blue"><font color="blue">regulatory</font> approval</font>s, or to <font color="blue">comply with</font> ongoing and     changing  <font color="blue">regulatory</font> <font color="blue">requirement</font>s, could delay or <font color="blue">prevent sales</font> of our     <font color="blue">current products</font> or any other products we may develop</td>
    </tr>
    <tr>
      <td>The field testing, <font color="blue">manufacture</font>, sale and use of <font color="blue">plant health products</font>,     including Messenger, <font color="blue">Messenger </font>STS, ProAct, N-Hibit, employ, <font color="blue">MightyPlant </font>and     other products we may develop, are <font color="blue">extensively</font> <font color="blue">regulated by</font> the EPA and/or     state,  local  and <font color="blue">foreign governmental authorities</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">regulations</font>     <font color="blue">substantially</font>  increase the cost and time <font color="blue">associated with bringing</font> our     <font color="blue">current products</font> and any other products we may develop to market</td>
    </tr>
    <tr>
      <td>If we do     not  continue to receive the <font color="blue">necessary governmental approvals</font> to test,     <font color="blue">manufacture</font> and market these products, or if the <font color="blue">regulatory</font> authorities     revoke our approvals or <font color="blue">grant them</font> subject to <font color="blue">restrictions on</font> their use, we     may be unable to sell these products and our business may fail</td>
    </tr>
    <tr>
      <td>We are required to obtain <font color="blue"><font color="blue">regulatory</font> approval</font> from certain state and foreign     <font color="blue">regulatory</font> authorities before we market our products in those <font color="blue">jurisdictions</font></td>
    </tr>
    <tr>
      <td>Some of these <font color="blue">jurisdictions</font> may apply <font color="blue">different</font> criteria than the EPA in     <font color="blue">connection</font> with their approval processes</td>
    </tr>
    <tr>
      <td>Although we are authorized to sell     <font color="blue"><font color="blue">Messenger </font>STS </font>in                                         24       _________________________________________________________________       49 states for use on virtually all crops for <font color="blue">crop production</font> and disease     <font color="blue">management</font>, and to sell <font color="blue"><font color="blue">Messenger </font>STS </font><font color="blue">in California</font> for use on <font color="blue">strawberries</font>,     citrus, grapes and fruiting vegetables, such as tomatoes and peppers, for     disease <font color="blue">management</font>, we have not received approval of Messenger, <font color="blue">Messenger </font>    STS  or  N-Hibit for use on other crops <font color="blue">in California</font></td>
    </tr>
    <tr>
      <td><font color="blue">In January </font>2006, <font color="blue">ProAct     </font>was  approved for use in Germany as a <font color="blue">plant strengthener</font></td>
    </tr>
    <tr>
      <td>We have also     received  <font color="blue">authorization</font>  to  sell Messenger, or are exempt from formal     <font color="blue">authorization</font> <font color="blue">requirement</font>s, in at least 26 <font color="blue">foreign countries</font>, including     Spain, Germany, Greece, Turkey, Mexico, China and six <font color="blue">Central American     </font>countries</td>
    </tr>
    <tr>
      <td>Our <font color="blue">registration</font> in China is temporary and limited to the sale of     <font color="blue">Messenger </font> for  use  on  tomatoes, peppers, tobacco, and rapeseed</td>
    </tr>
    <tr>
      <td>Our     <font color="blue">registration</font>  in Spain was limited to the sale of <font color="blue">Messenger </font>for use on     tomatoes, peppers, cucumbers, melons, <font color="blue">strawberries</font>, lettuce, citrus and     olives and was extended to all crops in early 2006</td>
    </tr>
    <tr>
      <td>The EPA has approved the     use  of <font color="blue"><font color="blue">Messenger </font>STS </font>and we are currently in the process of obtaining     foreign <font color="blue">registration</font>s for this product, but there can be no assurance that     such <font color="blue">registration</font>s will be obtained on acceptable terms</td>
    </tr>
    <tr>
      <td>Neither <font color="blue">employ nor</font> <font color="blue">MightyPlant </font>are pesticides and they are not <font color="blue">regulated by</font>     the EPA However, several states and <font color="blue">foreign governments regulate both</font>     products</td>
    </tr>
    <tr>
      <td>Many  states  regulate  <font color="blue">employ as</font> a <font color="blue">plant amendment</font> or soil     <font color="blue">conditioner</font> and some of these states and foreign <font color="blue">regulatory</font> authorities     require the submission and review of <font color="blue">performance data</font> and other information     prior to granting their approval</td>
    </tr>
    <tr>
      <td>We are authorized to <font color="blue">sell employ</font> in 33     states and <font color="blue">no <font color="blue">foreign countries</font></font></td>
    </tr>
    <tr>
      <td><font color="blue">MightyPlant </font>is <font color="blue">classified by most</font> states as     a <font color="blue">fertilizer</font> and we are authorized to sell <font color="blue">MightyPlant </font>in 47 states and no     <font color="blue">foreign countries</font></td>
    </tr>
    <tr>
      <td>However, there can be no assurance that we will obtain     approval to <font color="blue">sell employ</font> or <font color="blue">MightyPlant </font>in other states or <font color="blue">foreign countries</font></td>
    </tr>
    <tr>
      <td>If we <font color="blue">significant</font>ly modify our <font color="blue">current products</font>’ designs as a result of our     ongoing  research  and  <font color="blue">development</font> projects, <font color="blue">additional</font> EPA and other     <font color="blue"><font color="blue">regulatory</font> approval</font>s may be required</td>
    </tr>
    <tr>
      <td>Moreover, we <font color="blue">cannot assure</font> you that we     will  be able to obtain approval for marketing <font color="blue">additional</font> harpin-based     products or <font color="blue">product extensions</font> that we may develop</td>
    </tr>
    <tr>
      <td>For example, while the     EPA has in place a <font color="blue">registration</font> procedure for products such as <font color="blue">Messenger </font>    that is streamlined in <font color="blue">comparison</font> to the <font color="blue">registration</font> procedure for chemical     pesticides, there can be no assurance that all of our products or product     <font color="blue">extensions will</font> be eligible for the <font color="blue">streamlined procedure</font> or that the EPA     will not impose <font color="blue">additional</font> <font color="blue">requirement</font>s that could make the procedure more     time-consuming and costly for any <font color="blue">future products</font> we may develop</td>
    </tr>
    <tr>
      <td>Even if we obtain all necessary <font color="blue"><font color="blue">regulatory</font> approval</font>s to market and sell our     <font color="blue">current products</font> and any other products we may develop, these <font color="blue">products will</font>     be subject to <font color="blue">continuing review</font> and extensive <font color="blue">regulatory</font> <font color="blue">requirement</font>s</td>
    </tr>
    <tr>
      <td>The     EPA, as well as state and <font color="blue">foreign governmental authorities</font>, could withdraw a     <font color="blue">previously</font>  approved  product  from  the  <font color="blue">market upon discovery</font> of new     information, including an <font color="blue">inability</font> to <font color="blue">comply with</font> <font color="blue">regulatory</font> <font color="blue">requirement</font>s     or the occurrence of <font color="blue">unanticipated problems with</font> the product, or for other     reasons</td>
    </tr>
    <tr>
      <td>In addition, federal, state and foreign <font color="blue">regulations</font> relating to     <font color="blue">crop production</font> and <font color="blue">protection products</font> developed through <font color="blue">bio<font color="blue">technology</font></font> are     subject to <font color="blue">public concerns</font> and <font color="blue">political circumstances</font> and, as a result,     <font color="blue">regulations</font> have changed and may change <font color="blue">substantially</font> in the future</td>
    </tr>
    <tr>
      <td><font color="blue">These     </font>changes may result in <font color="blue">limitations on</font> the <font color="blue">manufacturing</font>, marketing or use of     our <font color="blue">current products</font> or any other products we may develop and <font color="blue">commercialize</font></td>
    </tr>
    <tr>
      <td>Our product <font color="blue">development</font> efforts, which are <font color="blue">based on</font> an <font color="blue">innovative <font color="blue">technology</font></font>     that is <font color="blue">commercially unproven</font>, may not be successful</td>
    </tr>
    <tr>
      <td>Our harpin and harpin-related <font color="blue">technology</font> is new and <font color="blue">commercially unproven</font></td>
    </tr>
    <tr>
      <td>It may take years and <font color="blue">significant</font> capital investment to develop viable     <font color="blue">enhancement</font>s of our <font color="blue">current products</font> or any <font color="blue">new products</font> we may develop     <font color="blue">based on</font> our harpin and harpin-related <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>Risks inherent in the     <font color="blue">development</font>  of  products <font color="blue">based on</font> innovative <font color="blue">technologies</font> include the     <font color="blue">possibility</font> that:       •       <font color="blue">new products</font> or product <font color="blue">enhancement</font>s will be uneconomical to market or     will be <font color="blue">difficult</font> to produce on a large scale;       •       <font color="blue"><font color="blue">proprietary</font> rights</font> of <font color="blue">third <font color="blue">parties will</font> prevent us from marketing</font>     products; and       •       <font color="blue">third <font color="blue">parties will</font> market</font> superior or <font color="blue">equivalent products</font> or will market     their <font color="blue">products first</font></td>
    </tr>
    <tr>
      <td>Our  operating  results for a <font color="blue">particular quarter</font> or year are likely to     fluctuate, which could result in <font color="blue">uncertainty surrounding</font> our level of sales     and losses or earnings and possibly result in a decrease in our stock price</td>
    </tr>
    <tr>
      <td>For example, there were no sales of <font color="blue">Messenger </font>in the <font color="blue">fourth quarter</font> of 2001     and annual net <font color="blue">product sales</font> decreased 70prca from 2001 to 2004</td>
    </tr>
    <tr>
      <td>Numerous other     <font color="blue">factors will</font> contribute to the <font color="blue">unpredictability</font> of our operating results</td>
    </tr>
    <tr>
      <td>In     particular, our sales are expected to be <font color="blue">highly seasonal</font></td>
    </tr>
    <tr>
      <td>Sales of plant     protection and yield <font color="blue">enhancement</font> products depend on planting and growing     seasons, climatic <font color="blue">conditions</font> and economic and other variables, which we     expect to result in substantial <font color="blue">fluctuations</font> in our <font color="blue">quarterly sales</font> and     earnings</td>
    </tr>
    <tr>
      <td>For example, weather-related events such as droughts and floods,     <font color="blue">severe heat</font> and frost, hail, tornadoes and <font color="blue">hurricanes could decrease demand</font>     for our products and any <font color="blue">future products</font> we may develop, and have an adverse     <font color="blue">impact on</font> our operating results <font color="blue">from quarter</font> to quarter</td>
    </tr>
    <tr>
      <td>In addition, most     of  our expenses, such as employee compensation and <font color="blue">lease payments</font> for     <font color="blue">facilities</font>, are <font color="blue">relatively</font> fixed</td>
    </tr>
    <tr>
      <td>Our <font color="blue">expense levels</font> are based, in part, on     our <font color="blue">expectations</font> regarding <font color="blue">future sales</font></td>
    </tr>
    <tr>
      <td>As a result, any shortfall in sales     relative  to  our  <font color="blue">expectations</font> could cause <font color="blue">significant</font> changes in our     operating results <font color="blue">from quarter</font> to quarter</td>
    </tr>
    <tr>
      <td>Other <font color="blue">factors may also contribute</font>     to the <font color="blue">unpredictability</font> of our operating results, including the amount of     our products carried in inventory by in<font color="blue">dependent</font> <font color="blue"><font color="blue">distributor</font>s</font> and retailers,     the amount of <font color="blue">free product</font> to be given to retailers, the size and timing of     <font color="blue">significant</font> customer transactions, the delay or deferral of <font color="blue">customer use</font> of     our products and the fiscal or <font color="blue">quarterly budget cycles</font> of our customers</td>
    </tr>
    <tr>
      <td>For     example, customers may purchase large quantities of our <font color="blue">products under</font> a     promotion such as “buy one, get one free” in a <font color="blue">particular quarter</font> to store     and <font color="blue">use over long periods</font> of time, or time their purchases to <font color="blue">coincide with</font>     the  <font color="blue">availability</font>  of  capital,  either of which may cause <font color="blue">significant</font>     <font color="blue">fluctuations</font> in our operating results for a <font color="blue">particular quarter</font> or year</td>
    </tr>
    <tr>
      <td><font color="blue">Inability </font>to protect our patents and <font color="blue"><font color="blue">proprietary</font> rights</font> in the <font color="blue">United States </font>    and <font color="blue">foreign countries</font> could limit our ability to compete <font color="blue">effective</font>ly since     our <font color="blue">competitors</font> may take advantage of our patents or <font color="blue"><font color="blue">proprietary</font> rights</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">success depends</font> on our ability to obtain and maintain patent and other     <font color="blue">proprietary</font>-right protection for our <font color="blue">technology</font> and products in the United     States and other countries</td>
    </tr>
    <tr>
      <td>If we are unable to obtain or maintain these     <font color="blue">protections</font>, we may not be able to <font color="blue">prevent <font color="blue">third parties</font> from using</font> our     <font color="blue"><font color="blue">proprietary</font> rights</font></td>
    </tr>
    <tr>
      <td>We also rely on <font color="blue">trade secrets</font>, <font color="blue">proprietary</font> know-how and     <font color="blue">continuing technological innovation</font> to <font color="blue">remain competitive</font></td>
    </tr>
    <tr>
      <td>We have taken     measures to protect our <font color="blue">trade secrets</font> and know-how, including the use of     <font color="blue"><font color="blue">confidential</font>ity <font color="blue">agreements</font> with</font> our employees, consultants and advisors</td>
    </tr>
    <tr>
      <td>It     is possible that these <font color="blue"><font color="blue">agreements</font> may</font> be breached and that any remedies for     <font color="blue">breach will</font> not make us whole</td>
    </tr>
    <tr>
      <td>We <font color="blue">generally</font> control and <font color="blue">limit access</font> to, and     the  <font color="blue">distribution</font>  of, our <font color="blue">product documentation</font> and other <font color="blue">proprietary</font>     information</td>
    </tr>
    <tr>
      <td>Despite our efforts to protect these <font color="blue"><font color="blue">proprietary</font> rights</font>,     <font color="blue">unauthorized parties may copy aspects</font> of our products or obtain and use     information that we regard as <font color="blue">proprietary</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">also <font color="blue">cannot guarantee</font></font> that     other <font color="blue">parties will</font> not in<font color="blue">dependent</font>ly develop our know-how or otherwise     obtain access to our <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>The laws of some <font color="blue">foreign countries</font> do not protect <font color="blue"><font color="blue">proprietary</font> rights</font> to the     same  extent as the laws of the United States, and many companies have     <font color="blue">encountered</font>  <font color="blue">significant</font>  problems  and  incurred <font color="blue">significant</font> costs in     protecting their <font color="blue"><font color="blue">proprietary</font> rights</font> in these <font color="blue">foreign countries</font></td>
    </tr>
    <tr>
      <td>Patent law is <font color="blue">still evolving with respect</font> to the scope and <font color="blue">enforceability</font> of     claims in the fields in which we operate</td>
    </tr>
    <tr>
      <td>We are like many <font color="blue">bio<font color="blue">technology</font></font>     companies in that our <font color="blue">patent protection</font> is <font color="blue">highly uncertain</font> and involves     <font color="blue">complex legal</font> and <font color="blue">technical questions</font> for <font color="blue">which legal principles</font> are not     <font color="blue">firmly established</font></td>
    </tr>
    <tr>
      <td>Our patents and those patents for which we have license     rights  may  be  challenged, narrowed, invalidated or <font color="blue"><font color="blue">circumvent</font>ed</font></td>
    </tr>
    <tr>
      <td>In     addition, our <font color="blue">issued patents may</font> not contain claims <font color="blue">sufficiently broad</font> to     <font color="blue">protect us against <font color="blue">third parties</font> with</font> similar <font color="blue">technologies</font> or products, or     <font color="blue">provide us with</font> any <font color="blue">competitive advantage</font></td>
    </tr>
    <tr>
      <td>We are not certain that our     <font color="blue"><font color="blue">pending patent applications</font> will</font> be issued</td>
    </tr>
    <tr>
      <td>Moreover, our <font color="blue">competitors</font> could     challenge or <font color="blue">circumvent</font> our patents or <font color="blue">pending patent applications</font></td>
    </tr>
    <tr>
      <td><font color="blue">The US Patent and Trademark Office </font>and the courts have not established a     <font color="blue">consistent policy</font> regarding the breadth of claims allowed in <font color="blue">bio<font color="blue">technology</font></font>     patents</td>
    </tr>
    <tr>
      <td>The allowance of broader claims may increase the                                         26       _________________________________________________________________       incidence  and cost of <font color="blue">patent <font color="blue">interference</font> <font color="blue">proceedings</font></font> and the risk of     <font color="blue"><font color="blue">infringement</font> <font color="blue">litigation</font></font></td>
    </tr>
    <tr>
      <td>On the other hand, the allowance of narrower claims     may limit the value of our <font color="blue"><font color="blue">proprietary</font> rights</font></td>
    </tr>
    <tr>
      <td>Other <font color="blue">companies may</font> claim that we infringe their <font color="blue"><font color="blue">intellectual</font> property</font> or     <font color="blue"><font color="blue">proprietary</font> rights</font>, which could cause us to incur <font color="blue">significant</font> expenses or be     <font color="blue">prevented from selling</font> our <font color="blue">current products</font> or any other products we may     develop in the future</td>
    </tr>
    <tr>
      <td>Our <font color="blue">success depends</font> on our ability to operate <font color="blue">without infringing</font> the patents     and <font color="blue"><font color="blue">proprietary</font> rights</font> of <font color="blue">third parties</font></td>
    </tr>
    <tr>
      <td>Product <font color="blue">development</font> is inherently     uncertain in a <font color="blue">rapidly evolving technological <font color="blue">environment</font></font> in which there may     be <font color="blue">numerous patent applications pending</font>, many of which are <font color="blue">confidential</font> when     filed, with regard to similar <font color="blue">technologies</font></td>
    </tr>
    <tr>
      <td>Future patents issued to third     <font color="blue">parties may contain</font> claims that <font color="blue">conflict with</font> our patents</td>
    </tr>
    <tr>
      <td>Although we     believe that our <font color="blue">current products</font> do not infringe the <font color="blue"><font color="blue">proprietary</font> rights</font> of     any <font color="blue">third parties</font>, <font color="blue">third parties</font> could assert <font color="blue">infringement</font> claims <font color="blue">against us</font>     in the future</td>
    </tr>
    <tr>
      <td>Any <font color="blue">litigation</font> or <font color="blue">interference</font> <font color="blue">proceedings</font>, regardless of     their merit or outcome, would probably be costly and require <font color="blue">significant</font>     time and attention of our key <font color="blue">management</font> and <font color="blue">technical personnel</font></td>
    </tr>
    <tr>
      <td><font color="blue">Litigation     </font>or <font color="blue">interference</font> <font color="blue">proceedings</font> could also force us to:       •       stop or delay selling, <font color="blue">manufacturing</font> or using products that <font color="blue">incorporate</font>     the challenged <font color="blue"><font color="blue">intellectual</font> property</font>;       •       pay damages; or       •       enter into licensing or royalty <font color="blue">agreements</font> that may be unavailable on     acceptable terms</td>
    </tr>
    <tr>
      <td>If we do not <font color="blue">adequately</font> distinguish our products from <font color="blue">genetically</font> modified     plants and products, <font color="blue">public concerns</font> over those <font color="blue">products could negatively</font>     impact market <font color="blue">acceptance</font> of our products</td>
    </tr>
    <tr>
      <td><font color="blue">Claims  </font>that  the  output of <font color="blue"><font color="blue">genetically</font> modified plants</font> is unsafe for     <font color="blue">consumption</font> or that these <font color="blue">plants pose</font> a danger to the <font color="blue">environment</font> have led     to <font color="blue">public concerns</font> and <font color="blue">negative attitudes about <font color="blue">genetically</font> modified crops</font>,     <font color="blue">particularly</font> in Europe</td>
    </tr>
    <tr>
      <td>Our products are topically applied and do not modify the plant’s     DNA If the public or our customers perceive our <font color="blue">products as</font> products that     <font color="blue">genetically</font>  modify  plants, market <font color="blue">acceptance</font> and <font color="blue">registration</font> of our     products could be delayed, impaired or limited in countries with strong     political resistance to <font color="blue"><font color="blue">genetically</font> modified plants</font></td>
    </tr>
    <tr>
      <td>We may be exposed to <font color="blue">product <font color="blue">liability</font></font> claims, which could <font color="blue">adversely</font> affect     our <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We may be held liable or <font color="blue">incur costs</font> to settle <font color="blue">product <font color="blue">liability</font></font> claims if     our <font color="blue">current products</font> or any products we may develop, or any products that     use  or <font color="blue">incorporate</font> any of our <font color="blue">technologies</font>, cause injury or are found     unsuitable during product testing, <font color="blue">manufacturing</font>, marketing, sale or use</td>
    </tr>
    <tr>
      <td>These risks exist <font color="blue">even with respect</font> to any products that have received, or     may in the future receive, <font color="blue"><font color="blue">regulatory</font> approval</font>, <font color="blue">registration</font> or clearance     for  <font color="blue">commercial use</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot guarantee</font> that we will be able to avoid     <font color="blue">product <font color="blue">liability</font></font> exposure</td>
    </tr>
    <tr>
      <td>We currently maintain <font color="blue">product <font color="blue">liability</font></font> insurance at levels we believe are     sufficient and <font color="blue">consistent with industry standards</font> for <font color="blue">companies at</font> our stage     of <font color="blue">development</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot guarantee</font> that our <font color="blue">product <font color="blue">liability</font></font> insurance is     adequate, and, at any time, it is possible that <font color="blue">such <font color="blue">insurance coverage</font> may</font>     not be <font color="blue">available on commercially reasonable terms</font> or at all</td>
    </tr>
    <tr>
      <td>A product     <font color="blue">liability</font> claim could result in <font color="blue">liability</font> to <font color="blue">us greater than</font> our assets and     <font color="blue">insurance coverage</font></td>
    </tr>
    <tr>
      <td>Moreover, even if we have adequate <font color="blue">insurance coverage</font>,     <font color="blue">product <font color="blue">liability</font></font> claims or <font color="blue">recalls could</font> result in <font color="blue">negative publicity</font> or     force us to devote <font color="blue">significant</font> time and attention to matters other than     those that arise in the <font color="blue">normal course</font> of business</td>
    </tr>
    <tr>
      <td>Rapid changes in <font color="blue">technology</font> could render our <font color="blue">current products</font> or any other     products we may develop unmarketable or obsolete</td>
    </tr>
    <tr>
      <td>We are engaged in an <font color="blue">industry characterized by</font> extensive <font color="blue">research efforts</font>     and rapid technological <font color="blue">development</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">competitors</font>, many of which have     <font color="blue">substantially</font> greater technological and financial <font color="blue">resources than</font> we do, may     develop <font color="blue">plant protection</font> and yield <font color="blue">enhancement</font> <font color="blue">technologies</font> and products     that are more                                         27       _________________________________________________________________       <font color="blue">effective</font> than ours or that render our <font color="blue">technology</font> and <font color="blue">products obsolete</font> or     <font color="blue">uncompetitive</font></td>
    </tr>
    <tr>
      <td>To be successful, we will need to <font color="blue">continually enhance</font> our     current  products and any other products we may develop and to design,     develop and market <font color="blue">new products</font> that keep <font color="blue">pace with new technological</font> and     industry <font color="blue">development</font>s</td>
    </tr>
    <tr>
      <td><font color="blue">Inability </font> to <font color="blue">comply with</font> <font color="blue">regulations</font> applicable to our <font color="blue">facilities</font> and     procedures could delay, limit or prevent our research and <font color="blue">development</font> or     <font color="blue">manufacturing</font> <font color="blue">activities</font></td>
    </tr>
    <tr>
      <td>Our research and <font color="blue">development</font> and <font color="blue">manufacturing</font> <font color="blue">facilities</font> and procedures are     subject to <font color="blue">continual review</font> and <font color="blue">periodic inspection</font></td>
    </tr>
    <tr>
      <td>To <font color="blue">comply with</font> the     <font color="blue">regulations</font> applicable to these <font color="blue">facilities</font> and procedures, we must spend     funds,  time and effort in the areas of production, safety and quality     control and assurance to <font color="blue">help ensure</font> full <font color="blue">technical compliance</font></td>
    </tr>
    <tr>
      <td><font color="blue">If the EPA     </font>or another regulator determines that we are not in compliance, <font color="blue">regulatory</font>     approval of our <font color="blue">current products</font> or any other products we may develop could     be revoked, delayed or withheld or we may be required to limit or cease our     research and <font color="blue">development</font> or <font color="blue">manufacturing</font> <font color="blue">activities</font> or pay a monetary fine</td>
    </tr>
    <tr>
      <td>If  we  were  required  to limit or cease our research and <font color="blue">development</font>     <font color="blue">activities</font>,  our ability to develop <font color="blue">new products</font> would be impaired</td>
    </tr>
    <tr>
      <td>In     addition,  if  we  were  required  to limit or cease our <font color="blue">manufacturing</font>     <font color="blue">activities</font>,  our ability to produce our <font color="blue">current products</font> in commercial     <font color="blue">quantities would</font> be impaired or prohibited, which could have an adverse     effect on our sales</td>
    </tr>
    <tr>
      <td><font color="blue">Inability </font>to produce high quality products <font color="blue">could impair</font> our business</td>
    </tr>
    <tr>
      <td>To be successful, we will have to <font color="blue">manufacture</font> our <font color="blue">current products</font> in large     <font color="blue">quantities at</font> acceptable <font color="blue">costs while also preserving high product quality</font></td>
    </tr>
    <tr>
      <td>If we cannot maintain <font color="blue">high product quality on</font> a large scale, we may be     unable to achieve market <font color="blue">acceptance</font> of our products and our <font color="blue">sales would</font>     <font color="blue">likely suffer</font></td>
    </tr>
    <tr>
      <td>Moreover, we do not have back-up <font color="blue">manufacturing</font> systems and,     as a result, the failure of any component required in the <font color="blue">manufacturing</font>     <font color="blue">process could delay</font> or impair our ability to <font color="blue">manufacture</font> our products in the     quantities that we may require</td>
    </tr>
    <tr>
      <td>We intend to continue to make changes to our <font color="blue">manufacturing</font> processes and     <font color="blue">facilities</font>  in  order  to  improve  the  <font color="blue">efficiency</font> and quality of our     <font color="blue">manufacturing</font> <font color="blue">activities</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot guarantee</font> that we will be successful in     this regard or that the changes we make <font color="blue">will improve</font> our <font color="blue">manufacturing</font>     <font color="blue">activities</font></td>
    </tr>
    <tr>
      <td>We may encounter <font color="blue">difficult</font>ies in the production of our current     products or any <font color="blue">future products</font> we may develop, including <font color="blue">problems involving</font>     <font color="blue">manufacturing</font> processes or yields, packaging, <font color="blue">distribution</font>, storage, quality     control and assurance, shortages of <font color="blue">qualified personnel</font> or <font color="blue">compliance with</font>     <font color="blue">regulatory</font>  <font color="blue">requirement</font>s</td>
    </tr>
    <tr>
      <td>Even if we are successful in developing our     <font color="blue">manufacturing</font> capability and processes, there can be no assurance that we     <font color="blue">will satisfy</font> the <font color="blue">requirement</font>s of our <font color="blue"><font color="blue">distributor</font>s</font> or customers</td>
    </tr>
    <tr>
      <td>If third-party <font color="blue">manufacture</font>rs fail to perform <font color="blue">adequately</font>, we could be unable     to meet demand and our <font color="blue">revenues could</font> be <font color="blue">adversely</font> affected</td>
    </tr>
    <tr>
      <td>When our <font color="blue">manufacturing</font> plant is operating, we may depend on in<font color="blue">dependent</font>     <font color="blue">manufacture</font>rs for large-scale fermentation services and to perform certain     other portions of our <font color="blue">production process</font></td>
    </tr>
    <tr>
      <td>We intend to engage <font color="blue">additional</font>     third-party <font color="blue">manufacture</font>rs as necessary to perform these processes</td>
    </tr>
    <tr>
      <td>Any     failure or delay in the ability of our current or any future <font color="blue">manufacture</font>rs     to <font color="blue">provide us with</font> material they produce could <font color="blue">adversely</font> affect our ability     to produce our <font color="blue">current products</font> in the <font color="blue">quantities necessary</font> to satisfy the     <font color="blue">requirement</font>s of our <font color="blue"><font color="blue">distributor</font>s</font> or customers, or <font color="blue">could increase</font> our costs     associated  with  obtaining  <font color="blue">such materials</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot ensure</font> that our current or     future third-party <font color="blue">manufacture</font>rs will perform their <font color="blue">obligations</font> to meet our     <font color="blue">quality standards</font>, that we <font color="blue">will derive cost savings</font> or other benefits from     our  <font color="blue">relationships</font>  with  them  or  that we will be able to maintain a     satisfactory <font color="blue">relationship with them on terms</font> acceptable to us</td>
    </tr>
    <tr>
      <td>Moreover,     these <font color="blue">manufacture</font>rs may support products that <font color="blue">compete directly</font> or <font color="blue">indirectly</font>     with ours, or offer similar or <font color="blue">greater support</font> to our <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>If any of     these events were to occur, our business and <font color="blue">operations</font> could be <font color="blue">adversely</font>     affected</td>
    </tr>
    <tr>
      <td>28       _________________________________________________________________       <font color="blue">Inability </font>to address strain on our resources caused by growth could result     in in<font color="blue">effective</font> <font color="blue">management</font> of     our business</td>
    </tr>
    <tr>
      <td>If we experience growth and add <font color="blue">manufacturing</font>, marketing, sales, field     <font color="blue">development</font> or other personnel, both domestically and <font color="blue">internationally</font>,     during the <font color="blue">commercialization</font> of our <font color="blue">current products</font>, we expect that our     operating expenses and capital <font color="blue">requirement</font>s will increase</td>
    </tr>
    <tr>
      <td>Our ability to     manage growth <font color="blue">effective</font>ly requires us to continue to <font color="blue">expend funds</font> to improve     our operational, financial and <font color="blue">management</font> controls, reporting systems and     procedures</td>
    </tr>
    <tr>
      <td>In addition, we must <font color="blue">effective</font>ly expand, train and manage our     <font color="blue">employee base</font></td>
    </tr>
    <tr>
      <td>We will be unable to <font color="blue">effective</font>ly manage our business if we     are unable to timely and <font color="blue">successfully</font> alleviate the strain on our resources     caused by growth in our business, which could <font color="blue">adversely</font> affect our operating     results</td>
    </tr>
    <tr>
      <td><font color="blue">Inability </font> to  retain our key employees or other <font color="blue">skilled managerial</font> or     <font color="blue">technical personnel</font> <font color="blue">could impair</font> our ability to maintain or expand our     business</td>
    </tr>
    <tr>
      <td>We are highly <font color="blue">dependent</font> on the efforts and <font color="blue">abilities</font> of our <font color="blue">current key</font>     managerial and <font color="blue">technical personnel</font>, <font color="blue">particularly</font> Dr</td>
    </tr>
    <tr>
      <td>Rhett R Atkins, our     President and Chief Executive Officer, and Dr</td>
    </tr>
    <tr>
      <td>Zhongmin Wei, our Chief     Scientific Officer and Vice President of Research</td>
    </tr>
    <tr>
      <td>Our <font color="blue">success will depend</font>     in part on retaining the services of Drs</td>
    </tr>
    <tr>
      <td><font color="blue">Atkins and Wei </font>and our other     existing  key <font color="blue">management</font> and <font color="blue">technical personnel</font> and on attracting and     retaining new, highly <font color="blue">qualified personnel</font></td>
    </tr>
    <tr>
      <td><font color="blue">Inability </font>to retain our existing key <font color="blue">management</font> or <font color="blue">technical personnel</font> or to     attract <font color="blue">additional</font> <font color="blue">qualified personnel</font> could, among other things, delay our     sales,  marketing, <font color="blue">manufacturing</font> and research and <font color="blue">development</font> efforts</td>
    </tr>
    <tr>
      <td>Moreover, in our field, <font color="blue">competition</font> for qualified <font color="blue">management</font> and technical     personnel is intense and many of the <font color="blue">companies with which</font> we compete for     experienced personnel have <font color="blue">greater financial</font> and other <font color="blue">resources than</font> we do</td>
    </tr>
  </tbody>
</table>